on 27 Feb 2024
Last Applicant/ Owned by
168 Barclay Farms Center Suite #311
Cherry Hill,
NJ
08034
Serial Number
97652964 filed on 28th Oct 2022
Registration Number
7313813 registered on 27th Feb 2024
Correspondent Address
Jianmin Zhou
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Color is not claimed as a feature of the mark. nutraceuticals for use as a dietary supplement for pain relief, anxiety and depression reduction and treatment of certain forms of epilepsy, sold to doctors and patients containing plant based materials The mark consists of The word "RELIEFTA" spelled out with a capital "R" and the other letters in lowercase. The letter "E" has small circles growingRead More
nutraceuticals for use as a dietary supplement for pain relief, anxiety and depression reduction and treatment of certain forms of epilepsy, sold to doctors and patients containing plant based materials
03rd Jun 2022
21st Sep 2022
No 97652964
No Service/Collective Mark
No Legalhoop
No
No
No
No
No
No
No
No
26.01.09 -
Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
The mark consists of The word "RELIEFTA" spelled out with a capital "R" and the other letters in lowercase. The letter "E" has small circles growing in size from the 4 o'clock position and growing in size as it goes clockwise around the letter "E".
| Status Date | Action Taken |
|---|---|
| 27th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
| 27th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 12th Dec 2023 | PUBLISHED FOR OPPOSITION |
| 12th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Nov 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 06th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st Oct 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Oct 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Oct 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 20th Sep 2023 | NON-FINAL ACTION WRITTEN |
